SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-24-011920
Filing Date
2024-02-08
Accepted
2024-02-08 07:00:58
Documents
1
Period of Report
2023-09-30
Effectiveness Date
2024-02-08

Document Format Files

Seq Description Document Type Size
1 ARS tm244135d1_ars.pdf ARS 4208955
  Complete submission text file 0001104659-24-011920.txt   5798548
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: ARS | Act: 34 | File No.: 001-37759 | Film No.: 24606828
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)